Generics 6

Biosimilars

Medical devices

Nutraceuticals

Filters

Axitinib manufacturers

6 products found

Filters

6 products found

axitinib

Tablets 1 mg, 3 mg, 5 mg, 7 mg

Dossier type
EU CTD
Dossier status
Under Development
Country of origin
European Union
GMP approvals
EU GMP

Manufacturer #260

Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

axitinib

Tablets, film coated 1 mg, 5 mg, 3 mg, 7 mg

Dossier type
EU CTD
Dossier status
Ready
Country of origin
India
GMP approvals
EU GMP

Manufacturer #1338

Manufacturer usually replies in 6 days

axitinib

Tablets 1 mg, 5 mg

Dossier type
CTD
Dossier status
Ready
Country of origin
India
GMP approvals
EU GMP, WHO

Manufacturer #9406

Manufacturer usually replies in 7 days

Want to view all 6 products? Create your free account today!

Markets of interest Tyrosine kinase inhibitor, axitinib, is used to treat advanced renal cell carcinoma, a type of cancer that begins in the cells of the kidneys. The medication is usually prescribed to the people who have not been treated successfully with another drug. As a tyrosine kinase inhibitor, axitinib blocks the action of proangiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF) that contribute to cancer cells multiplication. The medication should be taken orally, at evenly spaced intervals, usually once every 12 hours. The drug is available for sale in different forms such as tablets (at concentrations of 1mg, 3mg, 5mg and 7mg) and film coated tablets (at concentrations of 1mg, and 5mg) from manufacturers in various countries including Y. The leading axitinib manufacturers and distributors are based in India and China. Licensing and brand names Axitinib was approved by the FDA for medical use in the United States in 2012, the same year by EMA , UK MHRA and Australian TGA. It is presently approved in many countries and is available in both generic and trade name versions. Axitinib is marketed in some countries under the trade name as Inlyta. The leading axitinib suppliers and manufacturers are the MSN Labs company in India and Chinese company Zhejiang Jiuzhou. Other manufacturing companies from European Union, Turkey and Argentina. have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with axitinib as an active ingredient. Target supply price The wholesale acquisition cost of the axitinib supply of 180 oral tablets in the United States is about 17 000 USD. In the EU the retail price of Axitinib film-coated tablets depending on the medication concentration in one tablet ranges between 773 EUR and 3 8b2 EUR per 56-tablet pack. The medication wholesale prices and commercial terms can vary depending on the supplier. Information from manufacturers We provide a detailed list of the axitinib manufacturers and suppliers that you are looking for. You can also find the dossier status of the drug that you order, and the GMP approvals of the different variants of the medication. The product description of all axitinib suppliers contains essential information about the medication, including clinical data, stability zones, and a list of countries where axitinib is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified axitinib suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.